All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 8, 2000, Pages 2889-2896

  Kurebayashi, Junichi ^a   Tanaka, Katsuhiro ^a   Otsuki, Takemi ^a   Moriya, Takuya ^b   Kunisue, Hironori ^a   Uno, Masako ^a   Sonoo, Hiroshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; IODINE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; PROTEIN P53; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; SODIUM ION; THYROGLOBULIN; THYROID PEROXIDASE; THYROID TRANSCRIPTION FACTOR 1; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CARCINOGENESIS; CASE REPORT; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CYTOGENETICS; ELECTRON MICROSCOPY; EXON; GENE MUTATION; GROWTH STIMULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KARYOTYPE; MALE; PAPILLARY CARCINOMA; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSAMMOMA BODY; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA;

ANIMALS; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; MICE, NUDE; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TRETINOIN; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 0034456589     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.8.2889     Document Type: Article

References (63)

1. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S
2. Anaplastic thyroid carcinoma: A therapeutic challenge
3. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas
4. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
5. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines
6. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
7. Nonautocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture
8. Poorly differentiated forms of papillary thyroid carcinoma: Distinctive entities or morphological patterns?
9. Clinicopathologic significance of poorly differentiated thyroid carcinoma
10. Establishment of a highly differentiated thyroid cancer cell line of Hurthle cell origin
11. Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1
12. Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the β-adrenergic receptor
13. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines
14. Establishment of xenografts and cell lines from well-differentiated human thyroid carcinoma
15. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis
16. Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers
17. Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines
18. Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)
19. Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1)
20. Production of multiple growth factors by a newly established human thyroid carcinoma cell line
21. Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells
22. Growth regulation of normal thyroids and thyroid tumors in man
23. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma
24. Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines
25. Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1)
26. Cytogenetical observations in five human anaplastic thyroid carcinomas
27. Establishment of a new human thyroid medullary carcinoma cell line. Morphological studies
28. Establishment and characterization of a human colony-stimulating factor-producing cell line from a squamous cell carcinoma of the thyroid gland
29. Tissue culture of human thyroid cancer
30. Human anaplastic thyroid carcinoma in tissue culture
31. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor
32. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer
33. Redifferentiation therapy with retinoic acid in follicular thyroid cancer
34. Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and papillary thyroid carcinoma
35. Semi-quantitative comparison of the differentiation markers and sodium iodide symporter in papillary thyroid carcinomas using RT-PCR method
36. Isolation and characterisation of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
37. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro
38. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
39. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
40. Medroxyprogesterone acetate inhibits interleukin-6 secretion from KPL-4 human breast cancer cell line both in vitro and in vivo: A possible mechanism of the anti-cachectic effect
41. Effects of 13-cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro
42. Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines
43. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells
44. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model
45. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
46. Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines
47. 3 and retinoids
48. The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells
49. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein
50. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells
51. DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60
52. Effects of retinoic acid on a new human erythromegakaryocytic cell line AP-217
53. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: A morphological and molecular analysis of four cell lines
54. Comparison of the effects of retinoic acid and nerve growth factor on PC12 cell proliferation, differentiation, and gene expression
55. Induction of retinoic acid receptor β mediates growth inhibition in retinoid resistant human colon carcinoma cells
56. Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid
57. Induction of PPARγ1 expression in human THP-1 monocytic leukemia cells by 9-cis-retinoic acid is associated with cellular growth suppression
58. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon α synthesis Stat1 and p48 induction
59. Retinoic acid receptor γ1 (RARγ1) levels control RARβ2 expression in SK-N-BE2(c) neuroblastoma cells and regulate a differentiation-apoptosis switch
60. Regulation of heregulin β1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathway
61. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells
62. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-β
63. Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells